The 2022 Option Agreement between Astellas and Taysha has expired. Regaining full rights to TSHA-102 Rett syndrome program enables Taysha to focus on driving its long-term value w ...
ORR and 79% DCR observed in heavily pretreated TMB-H or MSI-H/dMMR tumors across six major solid tumor types, including colorectal, lung, breast, ...
The 2022 Option Agreement between Astellas and Taysha has expired Regaining full rights to TSHA-102 Rett syndrome program enables Taysha to focus on driving its long-term value with full strategic fle ...
FinanceBuzz on MSN
10 'Boring' Jobs That Quietly Pay $95K+ (And Can’t Hire Fast Enough)
Discover stable, high-paying careers that may seem boring but deliver six-figure salaries, long-term security, and strong job ...
The Germany Hydrogen Bus Market is expected to continue its strong growth trajectory as environmental regulations tighten and ...
The global adhesives and sealants market is on track for remarkable expansion, projected to grow from USD 77.1 billion in ...
The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, ...
The FDA has named the first nine medications selected for its national priority review voucher program, which aims to shorten drug review timelines to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback